Simplex Trading’s Kymera Therapeutics KYMR Stock Holding History

Simplex Trading’s Portfolio KYMR Stock Details KYMR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$673K	Buy	+5,867	New	+$504K	﹤0.01%	3253
2025 Q1	–	Sell	-20	Closed	-$729	–	9106
2024 Q4	$0	Buy	+20	New	+$903	﹤0.01%	9112
2022 Q4	–	Sell	-3,922	Closed	-$105K	–	9832
2022 Q3	$85K	Buy	3,922 +3,646	+1,321%	+$96.1K	﹤0.01%	5743
2022 Q2	$5K	Sell	276 -3,449	-93%	-$80.6K	﹤0.01%	8833
2022 Q1	$157K	Buy	3,725 +3,720	+74,400%	+$157K	﹤0.01%	5505
2021 Q4	$0	Sell	5 -1,355	-100%	-$78.9K	﹤0.01%	10958
2021 Q3	$76K	Buy	1,360 +1,018	+298%	+$59K	﹤0.01%	6995
2021 Q2	$16K	Buy	+342	New	+$14.8K	﹤0.01%	8768

Other funds holding KYMR

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Simplex Trading's KYMR Position: Q2 2026 in Review

Simplex Trading opened a new position in Kymera Therapeutics (KYMR) in Q2 2026: 5,867 shares worth $673K. The stake represents ﹤0.01% of the portfolio and ranks #3253 among its holdings. This is a return to the name: Simplex Trading previously reported a position in KYMR as recently as Q4 2024.

Simplex Trading first reported a position in KYMR in Q2 2021 and has held it in 8 quarters since. 276 funds tracked by Wall St. Rank hold KYMR as of Q2 2026.

Simplex Trading held 5,867 shares of Kymera Therapeutics worth $673K as of Q2 2026.
Kymera Therapeutics was a new Simplex Trading position in Q2 2026.
Kymera Therapeutics made up ﹤0.01% of Simplex Trading's portfolio in Q2 2026, its #3253 holding.
Simplex Trading first reported a position in Kymera Therapeutics in Q2 2021 and has held it in 8 quarters since.
276 funds tracked by Wall St. Rank held Kymera Therapeutics as of Q2 2026.

Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.